Preliminary UK experience of dexmedetomi
✍
R. M. Venn; C. J. Bradshaw; R. Spencer; D. Brealey; E. Caudwell; C. Naughton; A.
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 235 KB
Dexmedetomidine, a highly selective and potent α~2~‐adrenergic agonist, has a potentially useful role as a sedative agent in patients requiring intensive care. As part of a larger European multicentre trial, a total of 119 postoperative cardiac and general surgical patients requiring ventilation and